RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
Synlett 2023; 34(13): 1603-1606
DOI: 10.1055/s-0042-1751440
DOI: 10.1055/s-0042-1751440
letter
Syntheses of Oxazolidinone-2,3-Fused Indoline and Azaindoline Derivatives
Abstract
We herein describe a practical synthetic method to access oxazolidinone-2,3-fused indoline and azaindoline derivatives via one-pot cyclization. These derivatives, which contain sp3-hybridized carbons, may be useful as new scaffolds in medicinal chemistry.
Key words
3-bromo-2-hydroxy-1-tosylindoline - 3-bromo-2-hydroxy-1-tosylazaindoline - oxazolidinone - isocyanate - cyclizationSupporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0042-1751440.
- Supporting Information
Publikationsverlauf
Eingereicht: 23. Februar 2023
Angenommen nach Revision: 08. März 2023
Artikel online veröffentlicht:
05. April 2023
© 2023. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References and Notes
- 1a Mérour J.-Y, Buron F, Plé K, Bonnet P, Routier S. Molecules 2014; 19: 19935
- 1b Motati DR, Amaradhi R, Ganesh T. Bioorg. Med. Chem. 2020; 28: 115830
- 1c Han Y, Dong W, Guo Q, Li X, Huang L. Eur. J. Med. Chem. 2020; 203: 112506
- 2a Taylor RD, MacCoss M, Lawson AD. G. J. Med. Chem. 2014; 57: 5845
- 2b Vitaku E, Smith DT, Njardarson JT. J. Med. Chem. 2014; 57: 10257
- 2c Blakemore DC, Castro L, Churcher I, Rees DC, Thomas AW, Wilson DM, Wood A. Nat. Chem. 2018; 10: 383
- 3a Lovering F, Bikker J, Humblet C. J. Med. Chem. 2009; 52: 6752
- 3b Lovering F. MedChemComm 2013; 4: 515
- 4 Nishi T, Mishima N, Kato H, Yamada K. Synlett 2021; 32: 1034
- 5 Benkovics T, Guzei IA, Yoon TP. Angew. Chem. Int. Ed. 2010; 49: 9153
- 6 Yamada K, Mishima N, Saito K, Nishi T. Tetrahedron 2021; 97: 132404
- 7 Yamada K, Ohta M, Kitamura G, Tsutsumiguchi S, Nishi T. Tetrahedron 2023; in press
- 8 CCDC 2234660 (1b) contains the supplementary crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures
- 9 Krishnakumar KS, Goudedranche S, Bouch D, Strazewski P. J. Org. Chem. 2011; 76: 2253
- 10 Jia S, Tian Y, Li X, Wang P, Lan Y, Yan H. Angew. Chem. Int. Ed. 2022; 61: e202206501
- 11 Abe T, Suzuki T, Anada M, Matsunaga S, Yamada K, Yamada K. Org. Lett. 2017; 19: 4275
- 12 (2R*,3S*)-3-Bromo-4-chloro-1-tosylindolin-2-ol (1a): Typical Procedure To a solution of 4-chloro-1-tosylindole (4a; 4.00 g, 13.1 mmol) and H2O (2.35 mL, 131 mmol) in acetone (80 mL) was added NBS (2.56 g, 14.4 mmol). The reaction mixture was stirred at room temperature for 7 h. The solvent was removed in vacuo, and the residue was diluted with brine and extracted with EtOAc. The organic layer was dried over MgSO4. The solvent was removed in vacuo, and the residue was purified by flash silica gel column chromatography (n-hexane/EtOAc = 8:1–2:1) to obtain 1a as a white solid (4.74 g, 90% yield); mp 116–118 °C. 1H NMR (500 MHz, CDCl3): δ = 7.75 (d, J = 8.6 Hz, 2 H), 7.48 (d, J = 8.6 Hz, 1 H), 7.27 (m, 1 H), 7.26 (d, J = 8.6 Hz, 2 H), 7.05 (d, J = 8.1 Hz, 1 H), 6.01 (s, 1 H), 5.04 (s, 1 H), 3.73 (brs, 1 H), 2.37 (s, 3 H). 13C NMR (125 MHz, CDCl3): δ = 145.1, 141.3, 135.2, 132.4, 132.2, 130.0, 127.8, 127.3, 125.1, 113.3, 93.5, 47.1, 21.7. HRMS (ESI): m/z [M + Na]+ calcd for C15H13BrClNNaO3S: 423.9386, 425.9365, and 427.9336; found: 423.9405, 425.9366, and 427.9362. (3aR*,8bR*)-8-Chloro-1-phenyl-4-tosyl-1,3a,4,8b-tetrahydro-2H-oxazolo[5,4-b]indol-2-one (2a): Typical Procedure Compound 1a (4.00 g, 9.93 mmol) was heated with phenyl isocyanate (1.77 g, 14.9 mmol) and cesium carbonate (4.84 g, 14.9 mmol) in THF (200 mL) at 80 °C for 2 h. The reaction mixture was diluted with EtOAc and washed with brine. The organic layer was dried over MgSO4. The solvent was removed in vacuo and the residue was crystallized from MeOH to obtain 2a as a white solid (3.63 g, 83% yield); mp 210–212 °C. 1H NMR (500 MHz, CDCl3): δ = 7.96 (d, J = 8.6 Hz, 2 H), 7.36 (d, J = 8.6 Hz, 2 H), 7.30–7.39 (m, 3 H), 7.20–7.25 (m, 4 H), 6.86 (d, J = 8.0 Hz, 1 H), 6.80 (d, J = 7.5 Hz, 1 H), 5.85 (d, J = 7.5 Hz, 1 H), 2.43 (s, 3 H). 13C NMR (125 MHz, CDCl3): δ = 154.4, 145.4, 142.5, 136.2, 135.4, 132.4, 132.2, 130.3, 129.4, 128.3, 127.9, 127.3, 125.3, 124.7, 112.0, 88.1, 62.2, 21.8. HRMS (ESI): m/z [M + Na]+ calcd for C22H17ClN2NaO4S: 463.0495 and 465.0466; found: 463.0492 and 465.0476.